What are the responsibilities and job description for the Associate Director, Biostatistics position at Stoke Therapeutics?
About Stoke:
Stoke Therapeutics (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine. Using Stoke’s proprietary approach, the company is developing antisense oligonucleotides (ASOs) to selectively restore naturally occurring protein levels. Stoke’s first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome and is currently being evaluated in a Phase 3 study. Stoke entered into a strategic collaboration with Biogen in 2025 to develop and commercialize zorevunersen for Dravet syndrome. Under the collaboration, Stoke retains exclusive rights for zorevunersen in the United States, Canada, and Mexico; Biogen receives exclusive rest of world commercialization rights
STK-002 is Stoke’s proprietary antisense oligonucleotide (ASO) in clinical development for the treatment of autosomal dominant optic atrophy (ADOA), the most common inherited optic nerve disorder. STK-002 has been granted orphan drug designation by the FDA. A Phase 1 study (OSPREY) of STK-002 in people with ADOA is now underway. The company is also conducting early research in Syngap1, a severe and rare neurodevelopmental disorder, in collaboration with Acadia Pharmaceuticals.
Stoke’s initial focus is on diseases of the central nervous system and the eye that are caused by a loss of ~50% of normal protein levels (haploinsufficiency). Proof of concept has been demonstrated in other organs, tissues, and systems, supporting broad potential for the Company’s proprietary approach.
Position Purpose:
The Associate Director, Biostatistics is a key contributor to clinical development, providing statistical leadership across all phases of clinical trials (Phases 1-4). They will join a highly collaborative Clinical Development team and partner cross-functionally with Data Management, Clinical Development Operations, and external stakeholders including consultants, CROs, and Key Opinion Leaders.
The Associate Director, Biostatistics, will have proven leadership ability in a fast-paced environment, influencing study design and data analysis while ensuring high-quality deliverables. This position will report to the Director of Biostatistics.
Key Responsibilities:
Stoke is located in Bedford, MA, and will be moving to a new location in Waltham, MA by the end of 2026. This position is a hybrid currently based in Bedford and will later be based in Waltham.
Travel:
This position will require approximately 5% travel.
Compensation & Benefits:
At Stoke Therapeutics, we are committed to offering a comprehensive, competitive and thoughtfully designed total rewards program.
The anticipated salary range for this role is $195,000 - $215,000. The final offer will be determined based on a variety of factors, including role scope, experience and qualifications, education, market benchmarks, internal equity, and geographic location. In addition to base salary, Stoke offers an annual bonus and equity participation.
Our benefits package includes medical, dental and vision insurance; life, long- and short-term disability insurance; paid parental leave; a 401K plan with company match, unlimited vacation time, tuition assistance and participation in our Employee Stock Purchase Program (ESPP).
Culture & Values:
At Stoke, we believe that innovation, the ability to successfully advance our ground-breaking science and having fun as a team are enhanced by being together in person, at least periodically. We allow for flexibility in work arrangements that balance individual’s needs and preferences with the needs of our business and our desire to foster a culture of collaboration and innovation.
Our values guide our work to deliver meaningful medicines for people who need them. We are committed to being true to ourselves, to our colleagues, and to the people with severe diseases who are counting on us. We embrace diversity within a unique culture that is defined by our values. Our employee-led Diversity, Inclusion, and Belonging (DIB) Committee underscores the importance of DIB to who we are and what we do.
Interested candidates: Please visit Stoke’s website to learn more and apply directly to the position listed on our Career Center:
https://www.stoketherapeutics.com/careers/
For more information, visit https://www.stoketherapeutics.com/.
All applicants will receive consideration for employment without regard to race, color, age, religion, sex, sexual orientation, gender identity, national origin, physical or mental disability or protected veteran status.
Stoke participates in E-Verify.
Stoke Therapeutics (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine. Using Stoke’s proprietary approach, the company is developing antisense oligonucleotides (ASOs) to selectively restore naturally occurring protein levels. Stoke’s first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome and is currently being evaluated in a Phase 3 study. Stoke entered into a strategic collaboration with Biogen in 2025 to develop and commercialize zorevunersen for Dravet syndrome. Under the collaboration, Stoke retains exclusive rights for zorevunersen in the United States, Canada, and Mexico; Biogen receives exclusive rest of world commercialization rights
STK-002 is Stoke’s proprietary antisense oligonucleotide (ASO) in clinical development for the treatment of autosomal dominant optic atrophy (ADOA), the most common inherited optic nerve disorder. STK-002 has been granted orphan drug designation by the FDA. A Phase 1 study (OSPREY) of STK-002 in people with ADOA is now underway. The company is also conducting early research in Syngap1, a severe and rare neurodevelopmental disorder, in collaboration with Acadia Pharmaceuticals.
Stoke’s initial focus is on diseases of the central nervous system and the eye that are caused by a loss of ~50% of normal protein levels (haploinsufficiency). Proof of concept has been demonstrated in other organs, tissues, and systems, supporting broad potential for the Company’s proprietary approach.
Position Purpose:
The Associate Director, Biostatistics is a key contributor to clinical development, providing statistical leadership across all phases of clinical trials (Phases 1-4). They will join a highly collaborative Clinical Development team and partner cross-functionally with Data Management, Clinical Development Operations, and external stakeholders including consultants, CROs, and Key Opinion Leaders.
The Associate Director, Biostatistics, will have proven leadership ability in a fast-paced environment, influencing study design and data analysis while ensuring high-quality deliverables. This position will report to the Director of Biostatistics.
Key Responsibilities:
- Lead statistical strategy for clinical trials from protocol development through study reporting, including study design, endpoint selection, sample size determination, and statistical methodology.
- Author and oversee Statistical Analysis Plans (SAPs) and contribute to Clinical Study Reports (CSRs), ensuring accuracy, quality and regulatory readiness.
- Analyze and interpret clinical trial data; oversee validation and quality control of TLFs; communicate statistical results and concepts clearly to cross-functional and non-statistical audiences.
- Partner with cross-functional teams to provide strategic statistical guidance and input across programs from Phase 1 through Phase 3, including regulatory submissions (e.g. New Drug Applications) and post-marketing studies.
- Contribute to key clinical development and regulatory documents including Clinical Development Plans, protocols, synopses, Investigator Brochures, submissions, and scientific publications.
- Represent Biostatistics in internal and external forums, including, for example, Investigator Meetings, Advisory Boards, and interactions with Key Opinion Leaders.
- Coordinate statistical and programming activities with CRO partners to ensure high-quality and timely deliverables.
- Collaborate closely with Clinical Development, Data Management, Clinical Development Operations, Medical Writing, and other internal departments to achieve alignment across departments.
- Maintain current knowledge of relevant issues related to statistics and trial design, drug development, Health Authority regulations, and competitive trends to inform strategic decision-making.
- Ph.D. in Statistics or Biostatistics with 6 years of industry experience, or Master’s degree with 8 years in a clinical trial setting.
- Strong Knowledge of FDA, EMA, and ICH guidance for drug
- Excellent working knowledge of CDISC requirements for regulatory submissions, including expertise with preparation and submission of data in STDM, ADaM, and SEND data standards and associated
- Demonstrated experience across Phase 1 to 3 clinical trial design, execution and data interpretation in both efficacy and safety. Submission experience is a plus.
- Experience working collaboratively with CROs to ensure high-quality and timely deliverables
- Excellent interpersonal skills, ability to convey statistical concepts and results to non-statisticians.
- Proficiency in SAS programming and at least one other programming language such as R for statistical analysis.
- Experience working in an environment where knowledge of and adherence to SOPs and regulatory guidelines are required.
- Excellent verbal and written communication
- Strong attention to detail and process orientation.
Stoke is located in Bedford, MA, and will be moving to a new location in Waltham, MA by the end of 2026. This position is a hybrid currently based in Bedford and will later be based in Waltham.
Travel:
This position will require approximately 5% travel.
Compensation & Benefits:
At Stoke Therapeutics, we are committed to offering a comprehensive, competitive and thoughtfully designed total rewards program.
The anticipated salary range for this role is $195,000 - $215,000. The final offer will be determined based on a variety of factors, including role scope, experience and qualifications, education, market benchmarks, internal equity, and geographic location. In addition to base salary, Stoke offers an annual bonus and equity participation.
Our benefits package includes medical, dental and vision insurance; life, long- and short-term disability insurance; paid parental leave; a 401K plan with company match, unlimited vacation time, tuition assistance and participation in our Employee Stock Purchase Program (ESPP).
Culture & Values:
At Stoke, we believe that innovation, the ability to successfully advance our ground-breaking science and having fun as a team are enhanced by being together in person, at least periodically. We allow for flexibility in work arrangements that balance individual’s needs and preferences with the needs of our business and our desire to foster a culture of collaboration and innovation.
Our values guide our work to deliver meaningful medicines for people who need them. We are committed to being true to ourselves, to our colleagues, and to the people with severe diseases who are counting on us. We embrace diversity within a unique culture that is defined by our values. Our employee-led Diversity, Inclusion, and Belonging (DIB) Committee underscores the importance of DIB to who we are and what we do.
Interested candidates: Please visit Stoke’s website to learn more and apply directly to the position listed on our Career Center:
https://www.stoketherapeutics.com/careers/
For more information, visit https://www.stoketherapeutics.com/.
All applicants will receive consideration for employment without regard to race, color, age, religion, sex, sexual orientation, gender identity, national origin, physical or mental disability or protected veteran status.
Stoke participates in E-Verify.
Salary : $195,000 - $215,000